
Covid-19: As lab execs sell shares worth millions, questions arise
Pfizer, Moderna, Novavax: executives at several American laboratories developing COVID-19 vaccines have recently pocketed millions of dollars by selling shares in their companies—raising questions about the propriety of ...
Nov 15, 2020
0
14